Visceral leishmaniasis is an endemic infection in Mediterranean countries, where it has become a frequent complication of acquired immunodeficiency syndrome (AIDS). The incidence of visceral leishmaniasis is increasing in Spain due to human immunodeficiency virus (HIV)-related cases, but some aspects of its epidemiology, clinical features, and management remain unknown. In addition, no comparative clinical studies about the disease in HIV-infected and non-HIV-infected patients have been reported. During a 24-year period, 120 cases of visceral leishmaniasis were diagnosed at our institution and 80 (66%) were associated with HIV infection. The mean age at diagnosis was higher in HIV-infected that in non-HIV-infected patients (33.2 versus 23.2 yr; p = 0.002), but the male/female ratio was similar in both groups. The main risk factor for HIV infection was intravenous drug abuse (78.7%). The clinical presentation of leishmaniasis was similar in both groups, but HIV-infected patients had a lower frequency of splenomegaly than HIV-negative individuals (80.8% versus 97.4%; p = 0.02). HIV-infected patients had a greater frequency and degree of leukopenia, lymphocytopenia, and thrombocytopenia. Most of them were profoundly immunosuppressed (mean CD4+ lymphocyte count, 90 cells/mm3) at the time of diagnosis of leishmaniasis, and 53.7% had AIDS. The sensitivity of serologic studies for Leishmania was significantly lower in HIV-infected than in non-HIV-infected patients (50% versus 80%; p < 0.001), but the diagnostic yield of bone marrow aspirate (67.1% versus 79.4%) and bone marrow culture (62.9% versus 66.6%) was similar in both groups. After initial treatment, the response rate was significantly lower in HIV-infected than in non-HIV-infected individuals (54.8% versus 89.7%; p = 0.001). The relapse rate was 46.2% and 7.5%, respectively (p < 0.001). Secondary prophylaxis with antimonial compounds or amphotericin B seems to be useful in preventing relapses in HIV-infected patients. The mortality rate was higher (53.7% versus 7.5%; p < 0.001) and the median survival time shorter (25 versus > 160 mo; p < 0.001) in AIDS patients than in HIV-negative individuals. Although leishmaniasis could contribute to death in a significant number of HIV-infected patients, it was the main cause of death in only a few of them. The CD4+ lymphocyte count and the use of highly active antiretroviral therapy and secondary prophylaxis for leishmaniasis were the most significant prognostic factors for survival in AIDS patients. Visceral leishmaniasis behaves as an opportunistic infection in HIV-infected individuals and should be considered as an AIDS-defining disease.

Patients undergoing heart surgery have a high frequency of VAP. VAP is associated with a poor prognosis. In this study, surveillance cultures failed as an anticipative diagnostic method.

No abstract

A 34-year-old male with AIDS was admitted to the the satisfaction of five or more criteria-at least two major criteria-of the eight listed.hospital with S. enteritidis bacteremia and received a 10-day course of amoxicillin/clavulanate. Six days later he was readmitted with Because serum ferritin levels may be high in many conditions that cause unexplained fever, measurement of serum ferritin should arthritis of the left knee and bacteremia, both due to S. enteritidis, and oral ciprofloxacin (750 mg b.i.d.) was given for 12 days. On not be done routinely to evaluate patients with fever of unknown origin. If serum ferritin levels are helpful at all in supporting the day 50, the arthritis relapsed, and S. enteritidis was isolated again; long-term therapy with ciprofloxacin (750 mg

We compared the efficacy of three techniques--minimal time to positivity (MTTP) of blood cultures (BCs), differential time to positivity (DTTP) of BCs obtained from the catheter and peripheral veins and the number of positive BCs--in predicting catheter involvement in patients with well-demonstrated catheter-related candidaemia (C-RC) and non-catheter-related candidaemia (NC-RC).C-RC was defined as isolation of the same Candida species from blood and catheter tip culture (≥15 cfu/plate). A ROC curve was created for each quantitative variable to determine the best cut-off for predicting C-RC.A total of 108 episodes of candidaemia were included (84 adults and 24 children; 67 C-RC and 41 NC-RC). These were caused mainly by C. albicans (49.1%) and C. parapsilosis (30.6%). The MTTP was significantly shorter in adult patients with C-RC than in those with NC-RC (29.8 vs. 36.8 hours; p 0.035), although no cut-off value provided acceptable accuracy. DTTP had high sensitivity but low specificity for predicting CRC. However, C-RC episodes had a significantly greater number of positive BCs than NC-RC episodes. The optimal cut-off for predicting C-RC was at least two positive BCs out of three, with the following validity values: sensitivity, 100%; specificity, 62.5%; positive predictive value, 83.3%; negative predictive value, 100%; accuracy, 87.0%.None of the tests evaluated allow a clear-cut prediction of C-RC and the criteria accepted for bacteraemia should not be automatically extrapolated to candidaemia. We found that a low number of positive BCs with Candida had a high negative predictive value for a catheter origin.